Unresectable Solid Neoplasm

Also known as: Unresectable Solid Tumor / Unresectable Solid Tumors

DrugDrug NameDrug Description
DB08912DabrafenibA kinase inhibitor used to treat patients with specific types of melanoma, non-small cell lung cancer, and thyroid cancer.
DrugDrug NamePhaseStatusCount
DB08142AT-75191Active Not Recruiting1
DB15029AZD-81861Active Not Recruiting1
DB12001Abemaciclib1Active Not Recruiting1
DB08885Aflibercept1Completed1
DB08875Cabozantinib1Completed1
DB04690Camptothecin1Active Not Recruiting2
DB00002Cetuximab1Active Not Recruiting1
DB08912Dabrafenib1Active Not Recruiting1
DB01248Docetaxel1Active Not Recruiting1
DB00947Fulvestrant1Active Not Recruiting1
DB00947Fulvestrant1Recruiting1
DB00619Imatinib1Active Not Recruiting1
DB06186Ipilimumab1Active Not Recruiting1
DB06186Ipilimumab1Recruiting1
DB00762Irinotecan1Active Not Recruiting2
DB15483Modified vaccinia ankara1Active Not Recruiting1
DB12340Navitoclax1Active Not Recruiting1
DB09035Nivolumab1Completed1
DB09035Nivolumab1Recruiting2
DB06132Nivolumab1Unknown Status1
DB09035Nivolumab1Unknown Status1
DB06306Onalespib1Active Not Recruiting2
DB09073Palbociclib1Active Not Recruiting1
DB09073Palbociclib1Recruiting1
DB09037Pembrolizumab1Active Not Recruiting1
DB09037Pembrolizumab1Completed1
DB18428RC1181Completed1
DB16751RLY-26081Recruiting1
DB11730Ribociclib1Active Not Recruiting1
DB11730Ribociclib1Recruiting1
DB06176Romidepsin1Active Not Recruiting1
DB11836Sapanisertib1Completed1
DB00398Sorafenib1Active Not Recruiting1
DB12887Tazemetostat1Withdrawn1
DB08911Trametinib1Active Not Recruiting2
DB07232Veliparib1Active Not Recruiting1
DB07232Veliparib1Unknown Status1
DB08881Vemurafenib1Active Not Recruiting1
DB00062Albumin human1 / 2Recruiting1
DB14547Chloride ion1 / 2Active Not Recruiting1
DB00515Cisplatin1 / 2Active Not Recruiting1
DB05996Glembatumumab vedotin1 / 2Withdrawn1
DB14865Human interleukin-21 / 2Recruiting1
DB06186Ipilimumab1 / 2Withdrawn1
DB13982Lutetium Lu-1771 / 2Recruiting1
DB06328Methoxyamine1 / 2Active Not Recruiting1
DB12340Navitoclax1 / 2Terminated1
DB09035Nivolumab1 / 2Withdrawn1
DB09037Pembrolizumab1 / 2Recruiting1
DB00642Pemetrexed1 / 2Active Not Recruiting1
DB12257Platinum1 / 2Active Not Recruiting1
DB01030Topotecan1 / 2Active Not Recruiting1
DB07232Veliparib1 / 2Active Not Recruiting1
DB11925Vistusertib1 / 2Terminated1
DB09035Nivolumab2Recruiting1
DB09037Pembrolizumab2Active Not Recruiting1